Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin and Bone Markers in T2DM
NCT06439758Phase 4Not yet recruiting
- Sponsor
- King Saud University
- Start
- Aug 2024
- Primary completion
- Aug 2025
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of metformin in type 2 diabetes mellitus (T2DM), sponsored by King Saud University. Planned start Aug 2024; status: not yet recruiting.
02
Drugs
metformin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT06439758.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06439758.